 Peripheral Arterial Disease
"Peripheral Arterial Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Descriptor ID |
D058729
|
| MeSH Number(s) |
C14.907.137.126.307.500 C14.907.617.671
|
| Concept/Terms |
Peripheral Arterial Disease- Peripheral Arterial Disease
- Arterial Disease, Peripheral
- Arterial Diseases, Peripheral
- Disease, Peripheral Arterial
- Diseases, Peripheral Arterial
- Peripheral Arterial Diseases
- Peripheral Artery Disease
- Artery Disease, Peripheral
- Artery Diseases, Peripheral
- Disease, Peripheral Artery
- Diseases, Peripheral Artery
- Peripheral Artery Diseases
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Arterial Disease".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Arterial Disease".
This graph shows the total number of publications written about "Peripheral Arterial Disease" by people in this website by year, and whether "Peripheral Arterial Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 | | 2010 | 5 | 0 | 5 | | 2011 | 5 | 1 | 6 | | 2012 | 5 | 2 | 7 | | 2013 | 8 | 1 | 9 | | 2014 | 8 | 1 | 9 | | 2015 | 15 | 2 | 17 | | 2016 | 14 | 0 | 14 | | 2017 | 20 | 1 | 21 | | 2018 | 19 | 3 | 22 | | 2019 | 18 | 3 | 21 | | 2020 | 32 | 0 | 32 | | 2021 | 31 | 0 | 31 | | 2022 | 28 | 0 | 28 | | 2023 | 18 | 0 | 18 | | 2024 | 19 | 3 | 22 | | 2025 | 6 | 0 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Peripheral Arterial Disease" by people in Profiles.
-
Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet. 2025 05 03; 405(10489):1580-1593.
-
Whipple MO, Xu S, Zhang D, Guralnik JM, Spring B, Tian L, Treat-Jacobson D, Zhao L, Criqui MH, McDermott MM. Home-Based Exercise and Patient-Reported Outcome Measures in Peripheral Artery Disease: The LITE Randomized Clinical Trial. Am J Cardiol. 2025 Jun 01; 244:41-47.
-
Smolderen KG, Ujueta F, Buckley Behan D, Vlaeyen JWS, Jackson EA, Peters M, Whipple M, Phillips K, Chung J, Mena-Hurtado C. Understanding the Pain Experience and Treatment Considerations Along the Spectrum of Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2025 Mar; 18(3):e000135.
-
Divakaran S, Harms HJ, Robertson M, Merugumala SK, Park MA, Kijewski MF, Martell LB, Morgan V, Barrett L, Perillo A, Yang D, Jarolim P, Feinberg MW, Gerhard-Herman MD, Belkin M, Lin AP, Creager MA, Bonaca MP, Di Carli MF. Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease. J Nucl Cardiol. 2025 Apr; 46:102143.
-
Torres IO, Mencacci Costa MR, Wohlauer M, Sim?o da Silva E, Le?o PP, De Luccia N. Outcomes of Acute Limb Ischemia at a Large Public Hospital in Brazil: Insights before, during and after the COVID-19 Pandemic. Ann Vasc Surg. 2025 Apr; 113:254-266.
-
Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S. Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11; 10(8):728-737.
-
Lakkireddy D, Angiolillo DJ, Charlton-Ouw K, Jefferson B, Peeran S, Bisharat M, Ortega-Paz L, Harxhi A, Kaul S, Michaud E, Juan S, Woods B, Damaraju CV, Fontana G, Bonaca MP. Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study). Clin Cardiol. 2024 Dec; 47(12):e70039.
-
Fowler X, Mehta K, Eid M, Gladders B, Kearing S, Moore KO, Creager MA, Austin AM, Feinberg MW, Bonaca MP, Greenland P, McDermott MM, Goodney PP. Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease. Vasc Med. 2024 12; 29(6):653-663.
-
Bonaca MP, Barnes GD, Bauersachs R, Bessada Y, Conte MS, Dua A, Hess CN, Serhal M, Mena-Hurtado C, Weitz JI, Beckman JA. Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement. J Am Coll Cardiol. 2024 Sep 03; 84(10):936-952.
-
Canonico ME, Low Wang CC, Hsia J, Debus ES, Nehler MR, Patel MR, Anand SS, Ycas J, Capell WH, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs R, Bonaca MP. Low-Dose Rivaroxaban Plus Aspirin in?Fragile Patients After Lower Extremity?Revascularization. J Am Coll Cardiol. 2024 Aug 27; 84(9):801-811.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|